trending Market Intelligence /marketintelligence/en/news-insights/trending/-DyEVe95TJ2WK8zPLtJnyA2 content esgSubNav
In This List

Valeritas Holdings signs $21M investment deal with Aspire Capital Fund

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet


Valeritas Holdings signs $21M investment deal with Aspire Capital Fund

Bridgewater, N.J.-based medical technology company Valeritas Holdings Inc. said it attracted a $21 million investment in the company.

Valeritas, which is developing technologies to treat patients with type 2 diabetes in the U.S. and China, said Chicago-based investment firm Aspire Capital Fund LLC agreed to purchase $21 million worth of the company's stock over a 30-month period.

Aspire Capital has already bought 791,557 shares of the company for $1.2 million following the agreement.